Omeros (OMER) Depreciation & Amortization (CF) (2010 - 2026)
Omeros (OMER) reported Depreciation & Amortization (CF) of $239000.0 for Q1 2026, down 17.3% on a YoY basis from $289000.0 in Q1 2025, and up 1.7% sequentially from $235000.0 in Q4 2025.
Omeros (OMER) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $239000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 17.3% year-over-year to $239000.0; the trailing twelve-month figure through Mar 2026 stood at $914000.0 (down 11.69% YoY), and the FY2025 full-year result was $964000.0, up 1.47% from the prior year.
- Depreciation & Amortization (CF) rose to $239000.0 in Q1 2026, from $235000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $301000.0 in Q4 2024 to a low of $163000.0 in Q4 2022.
- A 5-year average of $234235.3 and a median of $235000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) slumped 50.0% in 2022 and jumped 50.0% in 2023, its largest moves.
- Tracing OMER's Depreciation & Amortization (CF) over 5 years: stood at $163000.0 in 2022, then grew by 25.77% to $205000.0 in 2023, then jumped by 46.83% to $301000.0 in 2024, then fell by 21.93% to $235000.0 in 2025, then advanced by 1.7% to $239000.0 in 2026.
- Business Quant data shows OMER's Depreciation & Amortization (CF) at $239000.0 in Q1 2026, $235000.0 in Q4 2025, and $240000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | 239,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 239,000.00 |
| Mar 31, 2026 | 239,000.00 |
| Dec 31, 2025 | 235,000.00 |
| Dec 31, 2025 | 235,000.00 |
| Sep 30, 2025 | 240,000.00 |
| Sep 30, 2025 | 240,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 289,000.00 |
| Mar 31, 2025 | 289,000.00 |
| Dec 31, 2024 | 301,000.00 |
| Dec 31, 2024 | 301,000.00 |
| Sep 30, 2024 | 237,000.00 |
| Sep 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 208,000.00 |
| Jun 30, 2024 | 208,000.00 |
| Mar 31, 2024 | 204,000.00 |
| Mar 31, 2024 | 204,000.00 |
| Dec 31, 2023 | 205,000.00 |
| Dec 31, 2023 | 205,000.00 |